Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

EW

Edwards Lifesciences Corp

Nov 08 • 04:00PM ET

66.23

Dollar change +0.39
Percentage change 0.59	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO SPY IVV VUG VO XLV IHI VOT VHT

Scroll to Statements

Index	S&P 500	P/E	9.55	EPS (ttm)	6.93	Insider Own	1.79%	Shs Outstand	601.10M	Perf Week	-1.94%
Market Cap	39.29B	Forward P/E	27.07	EPS next Y	2.45	Insider Trans	-0.72%	Shs Float	579.27M	Perf Month	-2.97%
Income	4.16B	PEG	1.36	EPS next Q	0.55	Inst Own	90.12%	Short Float	1.42%	Perf Quarter	1.05%
Sales	5.87B	P/S	6.69	EPS this Y	2.49%	Inst Trans	2.33%	Short Ratio	1.34	Perf Half Y	-23.63%
Book/sh	16.18	P/B	4.09	EPS next Y	-4.90%	ROA	13.01%	Short Interest	8.22M	Perf Year	-0.02%
Cash/sh	7.50	P/C	8.83	EPS next 5Y	7.00%	ROE	17.93%	52W Range	58.93 - 96.12	Perf YTD	-13.14%
Dividend Est.	-	P/FCF	76.22	EPS past 5Y	15.35%	ROI	40.66%	52W High	-31.10%	Beta	1.11
Dividend TTM	-	Quick Ratio	2.89	Sales past 5Y	10.28%	Gross Margin	77.38%	52W Low	12.39%	ATR (14)	1.95
Dividend Ex-Date	-	Current Ratio	3.46	EPS Y/Y TTM	195.52%	Oper. Margin	27.22%	RSI (14)	42.54	Volatility	2.41% 2.76%
Employees	19800	Debt/Eq	0.07	Sales Y/Y TTM	0.92%	Profit Margin	70.82%	Recom	2.30	Target Price	74.68
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	713.03%	Payout	0.00%	Rel Volume	0.50	Prev Close	65.84
Sales Surprise	-12.31%	EPS Surprise	0.81%	Sales Q/Q	-8.54%	Earnings	Oct 24 AMC	Avg Volume	6.13M	Price	66.23
SMA20	-3.12%	SMA50	-2.02%	SMA200	-17.49%	Trades		Volume	3,083,363	Change	0.59%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70
Jul-25-24	Downgrade	JP Morgan	Overweight → Neutral	$105 → $72
Jul-25-24	Downgrade	BofA Securities	Buy → Neutral	$105 → $75
May-30-24	Initiated	Goldman	Buy	$107
May-22-24	Upgrade	Citigroup	Neutral → Buy	$98 → $105
May-14-24	Upgrade	Deutsche Bank	Hold → Buy
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102

Show Previous Ratings

Nov-09-24 12:19AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Nov-02-24 11:13AM	Kessler Topaz Meltzer & Check, LLP Encourages Edwards Lifesciences Corporation Investors with Losses to Contact the Firm (Newsfile)
Nov-01-24 08:55AM	Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance (Insider Monkey)
Oct-31-24 07:00AM	Edwards, Medtronic and Inari share trial data at TCT conference (MedTech Dive)
Oct-30-24 04:05PM	Data Presented at TCT Reinforce Edwards Lifesciences Commitment to Structural Heart Innovation (Business Wire)
11:00AM	Loading…
11:00AM	TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation (Business Wire)
Oct-29-24 04:13PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:05PM	JPMorgan views Edwards Lifesciences TAVR data positively (TipRanks)
05:45AM	Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW (PR Newswire)
Oct-28-24 03:04PM	Bernstein Lifts Edwards Lifesciences Rating, Sees Balanced Risk-Reward in Tavr Market (GuruFocus.com)
11:00AM	Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients (Business Wire)
09:15AM	International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors (Zacks)
Oct-27-24 12:05PM	Edwards Lifesciences price target raised to $85 from $80 at Barclays (TipRanks)
Oct-25-24 04:23PM	Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker (Investor's Business Daily)
03:01PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
07:00AM	Loading…
07:00AM	Edwards Lifesciences Corp (EW) Q3 2024 Earnings Call Highlights: Strong Growth in TMTT Sales ... (GuruFocus.com)
Oct-24-24 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics (Zacks)
05:11PM	Edwards Reverses Course, Falling On A Mixed Third-Quarter Report (Investor's Business Daily)
04:43PM	Edwards Lifesciences: Q3 Earnings Snapshot (Associated Press Finance)
04:37PM	Edwards Lifesciences Pops After Wrapping A Key Divestiture And Beating Profit Views (Investor's Business Daily)
04:21PM	Edwards Lifesciences Reports Third Quarter Results (Business Wire)
08:24AM	Heres Why Edwards Lifesciences Corporation (EW) Detracted (Insider Monkey)
Oct-22-24 01:13AM	Boston Scientific, Edwards and Dexcom usher in second week of earnings (MedTech Dive)
Oct-21-24 09:16AM	Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Oct-17-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024 (Business Wire)
Oct-16-24 10:12AM	Artisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations (Insider Monkey)
10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-08-24 05:39PM	Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain (GuruFocus.com) +6.20%
05:07PM	S&P 500 Gains and Losses Today: Falling Oil Prices Pressure Refining Stocks (Investopedia)
08:06AM	CMS begins national coverage review for tricuspid repair (MedTech Dive)
07:59AM	Loading…
07:59AM	Edwards Lifesciences price target lowered to $66 from $77 at Canaccord (TipRanks)
Oct-04-24 05:04PM	Vanguard Group Inc's Strategic Acquisition of Edwards Lifesciences Corp Shares (GuruFocus.com)
Sep-28-24 05:09PM	ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM (PR Newswire)
Sep-17-24 05:07PM	S&P 500 Gains and Losses Today: New Home Battery, Software Lift Enphase Stock (Investopedia)
Sep-05-24 05:30AM	Edwards cuts more than 500 employees after critical care sale (MedTech Dive)
Sep-04-24 11:28AM	Edwards Lifesciences Completes $4.2B Sale of Critical Care to BD (Design & Development Today)
Sep-03-24 04:30PM	Edwards Lifesciences Completes Sale of Critical Care (Business Wire)
Sep-02-24 04:12AM	Edwards Lifesciences reports positive TAVI trial results (Medical Device Network)
Aug-31-24 06:58PM	CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves (Business Wire)
12:35PM	First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves (Business Wire)
Aug-23-24 11:30AM	Edwards Lifesciences (EW) Up 19.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-21-24 07:00AM	Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference (Business Wire)
Aug-20-24 06:53AM	Edwards Lifesciences buys JC Medical from Genesis Medtech (Medical Device Network)
06:53AM	Edwards Lifesciences acquires JC Medical from Genesis Medtech (Medical Device Network)
Aug-19-24 07:25AM	Edwards continues M&A spree with Genesis TAVR tech (MedTech Dive)
Aug-16-24 07:27AM	Should You Hold Edward Lifesciences (EW) in Your Portfolio Now? (Zacks)
Aug-13-24 06:01PM	David Rolfe's Strategic Moves in Edwards Lifesciences Corp Highlight Q2 2024 Investments (GuruFocus.com)
Jul-29-24 09:15AM	Edwards Lifesciences (EW) Reliance on International Sales: What Investors Need to Know (Zacks)
Jul-26-24 03:24AM	Heard on the Street Thursday Recap: Detroit Blues (The Wall Street Journal)
Jul-25-24 07:05PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research) -31.34%
05:30PM	Heard on the Street Recap: Detroit Blues (The Wall Street Journal)
05:05PM	S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product (Investopedia)
04:23PM	Edwards Lifesciences Stock Plummeted Today. Here's Why (Investopedia)
04:10PM	Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker (Investor's Business Daily)
12:34PM	Edwards Lifesciences Stock Plunges 28% After Earnings. What Wall Street Thinks. (Barrons.com)
12:30PM	S&P 500s Biggest Loser Has a Heart Valve Problem (The Wall Street Journal)
12:01PM	Top Stock Movers Now: Molina Healthcare, Ford, Honeywell, and More (Investopedia)
11:48AM	Stocks to Watch Thursday: Ford, RTX, Warner Bros, Honeywell (The Wall Street Journal)
09:59AM	Lululemon downgraded, Birkenstock upgraded: Wall Street's top analyst calls (The Fly)
09:02AM	Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash (Zacks)
08:36AM	Why Is Edwards Lifesciences (EW) Stock Down 22% Today? (InvestorPlace)
04:52AM	Edwards Lifesciences to acquire JenaValve and Endotronix (Medical Device Network)
Jul-24-24 06:00PM	Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	Edwards Lifesciences (EW) Q2 Earnings Match Estimates (Zacks)
05:05PM	Edwards Plummets After Slashing Guidance For Its Biggest Moneymaker (Investor's Business Daily)
04:34PM	Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year (Investor's Business Daily)
04:24PM	Edwards Lifesciences: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Second Quarter Results (Business Wire)
04:15PM	Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix (Business Wire)
Jul-22-24 09:14AM	Edwards Lifesciences expands transcatheter valve replacement sector with Innovalve deal (Medical Device Network)
Jul-20-24 08:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jul-18-24 11:49AM	Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions (Zacks)
Jul-17-24 10:00AM	Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
07:05AM	Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024 (Business Wire)
Jul-16-24 06:53AM	Edwards Lifesciences buys mitral valve business Innovalve in $300m deal (Medical Device Network)
Jul-15-24 11:02AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings? (Zacks)
09:00AM	Edwards Lifesciences to Acquire Innovalve (Business Wire)
07:14AM	Edwards to acquire Innovalve, stake in Affluent Medical (MedTech Dive)
06:33AM	Affluent Medical signs deals with Edwards for structural heart products (Medical Device Network)
Jul-10-24 02:21PM	Final Trades: Edwards Lifesciences, First Citizens, UnitedHealth and iShares US Real Estate ETF (CNBC TV)
Jun-28-24 07:58AM	Is Edwards Lifesciences Corp (NYSE:EW) the Best Medical Stock to Buy in 2024? (Insider Monkey)
Jun-27-24 05:06AM	10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America (Insider Monkey)
Jun-26-24 02:12PM	Final Trades: Edwards Lifesciences, American Tower (CNBC TV)
Jun-20-24 05:48AM	Does Edwards Lifesciences Corporation (EW) Have Attractive Growth Opportunities? (Insider Monkey)
Jun-06-24 07:43AM	Sapien valve performs equally well for small and large aortic annuli, Edwards finds (MedTech Dive)
Jun-05-24 11:45AM	Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR (Business Wire)
Jun-04-24 04:45AM	BD to acquire Edwards Lifesciences Critical Care unit for $4.2bn (Medical Device Network)
Jun-03-24 04:30PM	Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal (Investor's Business Daily)
03:46PM	Becton Dickinson Buys Critical Care Unit From Edwards Lifesciences for $4.2B (Investopedia)
02:04PM	Calls of the Day: Costco, Edwards Lifesciences, Citigroup, American Express (CNBC TV)
11:35AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
08:25AM	Becton Dickinson to Acquire Edwards Lifesciences Unit for $4.2 Billion in Cash (The Wall Street Journal)
06:30AM	Edwards Lifesciences to Sell Critical Care to BD (Business Wire)
06:30AM	BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader (PR Newswire)
May-24-24 10:57AM	Here's Why You Should Retain Edward Lifesciences (EW) for Now (Zacks)
May-14-24 04:33PM	Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint (Benzinga)
07:53AM	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 (MT Newswires)
May-13-24 05:52PM	Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing (MT Newswires)
02:20PM	Market Chatter: Edwards Lifesciences Faces EU Antitrust Complaint By Meril (MT Newswires)
May-08-24 07:21PM	Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability (Business Wire)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wood Larry L	Global President TAVR & Surg	Nov 05 '24	Sale	65.91	25,000	1,647,862	198,526	Nov 05 05:07 PM
Wood Larry L	Officer	Nov 05 '24	Proposed Sale	65.91	25,000	1,647,862		Nov 05 04:11 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 15 '24	Option Exercise	45.28	5,000	226,384	51,936	Oct 15 05:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 15 '24	Sale	69.51	5,000	347,534	46,936	Oct 15 05:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 11 '24	Option Exercise	45.28	5,000	226,384	51,936	Sep 11 06:06 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 11 '24	Sale	66.77	5,000	333,826	46,936	Sep 11 06:06 PM
Chopra Daveen	CVP, TMTT	Aug 20 '24	Sale	69.95	1,250	87,438	29,333	Aug 20 07:42 PM
Chopra Daveen	Officer	Aug 20 '24	Proposed Sale	69.95	1,250	87,438		Aug 20 05:12 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '24	Option Exercise	45.28	5,000	226,384	51,936	Aug 14 05:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '24	Sale	66.08	5,000	330,420	46,936	Aug 14 05:58 PM
BOBO DONALD E JR	Officer	Aug 14 '24	Proposed Sale	66.08	15,000	991,260		Aug 14 04:19 PM
Lippis Daniel J.	CVP, JAPAC	Jul 11 '24	Option Exercise	45.28	500	22,638	23,689	Jul 11 05:38 PM
Lippis Daniel J.	CVP, JAPAC	Jul 11 '24	Sale	94.18	500	47,090	23,189	Jul 11 05:38 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jul 10 '24	Option Exercise	45.28	5,000	226,384	51,936	Jul 10 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jul 10 '24	Sale	93.29	5,000	466,474	46,936	Jul 10 05:36 PM
Lippis Daniel J.	CVP, JAPAC	Jun 20 '24	Option Exercise	45.28	535	24,223	24,048	Jun 20 05:44 PM
Lippis Daniel J.	CVP, JAPAC	Jun 20 '24	Sale	90.00	535	48,150	23,513	Jun 20 05:44 PM
Ullem Scott B.	CVP, Chief Financial Officer	Jun 20 '24	Option Exercise	45.28	5,625	254,681	36,186	Jun 20 05:43 PM
Ullem Scott B.	CVP, Chief Financial Officer	Jun 20 '24	Sale	87.51	5,625	492,258	30,561	Jun 20 05:43 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 12 '24	Option Exercise	45.28	5,000	226,384	51,936	Jun 12 05:19 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 12 '24	Sale	87.54	5,000	437,696	46,936	Jun 12 05:19 PM
Zovighian Bernard J	CEO	May 30 '24	Sale	87.68	8,617	755,539	68,218	May 30 05:10 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 21 '24	Option Exercise	45.28	5,625	254,681	36,186	May 21 05:09 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 21 '24	Sale	90.45	5,625	508,803	30,561	May 21 05:09 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Option Exercise	45.28	5,000	226,384	52,750	May 13 05:45 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Sale	87.81	5,000	439,038	47,750	May 13 05:45 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Option Exercise	36.75	857	31,495	25,333	May 09 07:40 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Sale	85.60	857	73,359	23,890	May 09 07:40 PM
Zovighian Bernard J	CEO	May 04 '24	Option Exercise	0.00	6,265	0	50,554	May 07 05:53 PM
Zovighian Bernard J	CEO	May 06 '24	Buy	85.74	580	49,753	3,268	May 07 05:53 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 04 '24	Option Exercise	0.00	7,465	0	25,905	May 06 07:18 PM
Szyman Catherine M.	CVP, Critical Care	May 04 '24	Option Exercise	0.00	5,796	0	49,018	May 06 07:18 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 04 '24	Option Exercise	0.00	4,157	0	177,969	May 06 07:18 PM
Wood Larry L	Global President TAVR & Surg	May 04 '24	Option Exercise	0.00	6,675	0	220,022	May 06 07:17 PM
Chopra Daveen	CVP, TMTT	May 04 '24	Option Exercise	0.00	4,713	0	27,172	May 06 07:17 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 04 '24	Option Exercise	0.00	5,855	0	45,144	May 06 07:16 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Option Exercise	36.75	29,350	1,078,612	33,836	May 02 06:05 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Sale	84.77	29,350	2,487,966	4,486	May 02 06:05 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Option Exercise	36.75	14,400	529,200	188,249	May 01 05:17 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Sale	84.21	14,400	1,212,687	173,849	May 01 05:17 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Option Exercise	36.75	7,250	266,438	26,324	Apr 30 04:56 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Sale	85.80	7,250	622,062	19,074	Apr 30 04:56 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Option Exercise	36.75	8,000	294,000	47,503	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Sale	71.86	8,000	574,880	39,503	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Option Exercise	45.28	8,658	392,006	222,452	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Sale	71.86	8,658	622,164	213,794	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Sale	74.62	29,350	2,190,043	4,486	Dec 13 07:04 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Option Exercise	59.26	3,500	207,398	27,450	Dec 06 05:01 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Sale	70.00	3,500	245,006	23,950	Dec 06 05:01 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Nov 13 05:21 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Sale	65.30	8,660	565,460	213,794	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Option Exercise	36.75	6,000	220,500	45,503	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Sale	65.30	6,000	391,780	39,503	Nov 13 05:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EW

Edwards Lifesciences Corp

Upgrade your FINVIZ experience